ArticleJournal of diabetes research2026
Keap1 Deficiency Promotes Macrophage M2 Polarization and Protects β Cells.
Article in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundProgressive pancreatic β-cell injury is a core feature of Type 2 diabetes mellitus (T2DM). Imbalance between macrophage M1 and M2 polarization, driven by chronic inflammation, is a key contributor to this injury. The Keap1-Nrf2-ARE pathway regulates macrophage polarization and inflammatory responses, but whether it affects pancreatic β-cell survival through macrophages is unknown.
methodsWe generated a Keap1-knockout THP-1 line using CRISPR-Cas9, differentiated the cells into M0 macrophages with PMA, polarized them toward M2 with IL-4/IL-13, and cocultured them with MIN6 cells injured by LPS.
resultsKeap1 knockout increased M2 polarization efficiency and reduced the nuclear-to-cytoplasmic ratio of NF-κB p65, with lower IL-1β and TNF-α mRNA expression. After coculture with LPS-injured MIN6 cells, the Keap1-KO-M2 group showed higher MIN6 viability and less apoptosis. The antiapoptotic protein Bcl-2 rose, whereas the proapoptotic factors Bax and cleaved-caspase3 declined; MDA content fell, whereas HO-1 and SOD levels climbed.
conclusionThese findings indicate that Keap1 deficiency attenuates LPS-induced pancreatic β-cell injury by increasing macrophage M2 polarization efficiency and expanding the M2 population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.